Eye Implant Device with Arcuate Scaffold for Drug Delivery
Summary
USPTO published patent application US20260096927A1 for an aqueous humor outflow device featuring an arcuate scaffold for drug delivery. The arcuate scaffold extends continuously circumferentially and is sized to fit within the conventional aqueous humor outflow pathway of a mammalian eye. Inventors Douglas Cali and David Richardson disclosed that the scaffold contains docking stations or ports for retaining drug eluting or drug delivery implant devices.
What changed
USPTO published patent application US20260096927A1 for an arcuate scaffold eye implant device designed for drug delivery in the aqueous humor outflow pathway of mammalian eyes. The device comprises a continuous circumferential scaffold with docking stations or ports configured to retain drug eluting or drug delivery implant devices.
Medical device manufacturers developing ophthalmic implants or drug delivery systems should monitor this application as it may indicate competitive IP activity in the ocular drug delivery space. Pharmaceutical companies pursuing eye-related drug delivery technologies may also find this relevant for freedom-to-operate assessments.
What to do next
- Monitor for updates on patent application status
- Review for potential licensing opportunities if developing similar eye implant technology
Archived snapshot
Apr 12, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Method and Apparatus for Implant in the Conventional Aqueous Humor Outflow Pathway of a Mammalian Eye
Application US20260096927A1 Kind: A1 Apr 09, 2026
Inventors
Douglas CALI, David RICHARDSON
Abstract
An aqueous humor outflow device comprises an arcuate scaffold that extends continuously in a circumferential direction from a first end to a second end of the aqueous humor outflow device and has a cross-sectional area that allows the arcuate scaffold to fit within a conventional aqueous humor outflow pathway of a mammalian eye. The arcuate scaffold comprises a docking station or a port within which to retain an implant device, such as a drug eluting device or a drug delivery device.
CPC Classifications
A61F 9/00781
Filing Date
2025-12-09
Application No.
19414092
Related changes
Get daily alerts for USPTO Patent Applications - Prosthetics (A61F)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Prosthetics (A61F) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.